The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Direct Activation of Cyclin-Dependent Kinase 2 by Human Papillomavirus E7
Abstract
Addition of human papillomavirus (HPV) E7 CDK2/cyclin A or CDK2/cyclin E, purified from either insect cells or bacteria, dramatically upregulates histone H1 kinase activity. Activation is substrate specific, with a smaller effect noted for retinoblastoma protein (Rb). The CDK2 stimulatory activity is equivalent in high-risk (HPV type 16 [HPV16] and HPV31) and low-risk (HPV6b) E7. Mutational analyses of HPV16 E7 indicate that the major activity resides in amino acids 9 to 38, spanning CR1 and CR2, and does not require casein kinase II or Rb-binding domain functions. Synthetic peptides spanning HPV16 amino acid residues 9 to 38 also activate CDK2. Peptides containing this sequence that carry biotin on the carboxy terminus, as well as a photoactivated cross-linking group (benzophenone), also activate the complex and covalently associate with the CDK2/cyclin A complex in a specific manner requiring UV. Cross-linking studies that use protein monomers detect association of the E7 peptides with cyclin A but not CDK2. Together, our results indicate a novel mechanism whereby E7 promotes HPV replication by directly altering CDK2 activity and substrate specificity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“E7 can also directly associate with cdk2/cyclin A and cyclin E complexes, resulting in increased cdk2 activity [139,140,141]”
From The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis (2021) · cites this paper as [140]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product
Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017
Research works printed but not linked: 55
- 10.1002/j.1460-2075.1996.tb00546.x · DOI · Paper page
- Banks, L., C. Edmonds, and K. H. Vousden. 1990. Ability of the HPV16 E7 protein to bind RB and induce DNA synthesis is not sufficient for efficient transforming activity in NIH3T3 cells. Oncogene5:1383-1389.
- 10.1128/jvi.65.5.2254-2260.1991 · DOI
- 10.1016/0003-2697(76)90527-3 · DOI · Paper page
- 10.1023/A:1003745315540 · DOI
- 10.1038/sj.onc.1203375 · DOI
- 10.1101/gad.9.19.2335 · DOI
- 10.1159/000150373 · DOI
- Ciccolini, F., G. Di Pasquale, F. Carlotti, L. Crawford, and M. Tommasino. 1994. Functional studies of E7 proteins from different HPV types. Oncogene9:2633-2638.
- 10.1128/jvi.67.5.2521-2528.1993 · DOI
- 10.1128/jvi.67.2.716-725.1993 · DOI
- 10.1128/jvi.70.10.6862-6869.1996 · DOI
- 10.1016/S0955-0674(00)00151-4 · DOI
- 10.1128/jvi.21.3.1205-1209.1977 · DOI
- 10.1038/sj.onc.1204652 · DOI
- Fisher C. 1994. The cellular basis for development and differentiation in mammalian keratinizing epithelia p. 131-150. In I. Leigh B. Lane and F. Watt (ed.) The keratinocyte handbook. Cambridge University Press Cambridge United Kingdom.
- 10.1128/JVI.74.14.6622-6631.2000 · DOI
- Foster, S. A., and D. A. Galloway. 1996. Human papillomavirus type 16 E7 alleviates a proliferation block in early passage human mammary epithelial cells. Oncogene12:1773-1779.
- 10.1101/gad.11.16.2090 · DOI · Paper page
- 10.1128/JVI.75.16.7583-7591.2001 · DOI · Paper page
- 10.1016/S0092-8674(00)81519-6 · DOI · Paper page
- 10.1074/jbc.M202629200 · DOI
- 10.1128/JVI.76.20.10559-10568.2002 · DOI · Paper page
- 10.1128/JVI.75.15.6737-6747.2001 · DOI · Paper page
- 10.1073/pnas.93.21.11510 · DOI
- Howley P. M. 1996. Papillomavirinae : the viruses and their replication p. 2045-2076. In B. N. Fields D. M. Knipe and P. M. Howley (ed.) Fields virology 3rd ed. Lippincott-Raven Publishers Philadelphia Pa.
- 10.1128/jvi.66.3.1329-1335.1992 · DOI
- 10.1038/sj.onc.1202142 · DOI · Paper page
- 10.1101/gad.11.16.2101 · DOI · Paper page
- 10.1006/viro.1997.8851 · DOI · Paper page
- 10.1038/227680a0 · DOI · Paper page
- 10.1073/pnas.96.12.6626 · DOI
- 10.1074/jbc.M002713200 · DOI
- 10.1099/0022-1317-78-10-2607 · DOI
- Massimi, P., D. Pim, A. Storey, and L. Banks. 1996. HPV-16 E7 and adenovirus E1a complex formation with TATA box binding protein is enhanced by casein kinase II phosphorylation. Oncogene12:2325-2330.
- 10.1006/viro.1996.0008 · DOI
- 10.1146/annurev.cellbio.13.1.261 · DOI
- 10.1038/35008660 · DOI
- 10.1038/sj.onc.1204860 · DOI
- Münger K. and A. L. Halpern. 1997. HPV 16 E7: primary structure and biological properties p. 17-36. In G. Myers F. Sverdrup C. Baker A. McBride K. Münger H.-U. Bernard and J. Meissner (ed.) Human papillomaviruses 1997 compendium part III. Los Alamos National Laboratory Los Alamos N.Mex.
- 10.1093/carcin/19.8.1481 · DOI
- 10.1128/jvi.64.12.6121-6129.1990 · DOI
- 10.1016/S0092-8674(00)81007-7 · DOI
- 10.1016/0968-0004(92)90243-3 · DOI
- 10.1006/viro.1998.9359 · DOI
- 10.1016/0092-8674(90)90409-8 · DOI · Paper page
- 10.1101/gad.11.11.1464 · DOI
- 10.1128/JVI.72.3.1994-2001.1998 · DOI
- Tommasino, M., J. P. Adamczewski, F. Carlotti, C. F. Barth, R. Manetti, M. Contorni, F. Cavalieri, T. Hunt, and L. Crawford. 1993. HPV16 E7 protein associates with the protein kinase p33CDK2 and cyclin A. Oncogene8:195-202.
- 10.1126/science.2157286 · DOI · Paper page
- 10.1128/jvi.67.4.2402-2407.1993 · DOI · Paper page
- 10.1021/bi9903446 · DOI
- Zerfass-Thome, K., W. Zwerschke, B. Mannhardt, R. Tindle, J. W. Botz, and P. Jansen-Durr. 1996. Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene13:2323-2330.
- 10.1101/gad.827700 · DOI
- 10.1038/nrc798 · DOI
Cited by
Basukala, O., & Banks, L. (2021) · Viruses · doi:10.3390/v13101892 · Cited by 137
Metadata
- Authors
- He, W., Staples, D., Smith, C., & Fisher, C.
- Affiliations
- Genomics-ID
- Research Operations, Pharmacia Corp., Kalamazoo, Michigan 49006
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2003-10
- Volume
- 77
- Issue
- 19
- Pages
- 10566-10574
- ISSN
- 0022-538X
- 1098-5514
- Cited by
- 61
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review